A detailed history of Bennett Selby Investments LP transactions in Amgen Inc stock. As of the latest transaction made, Bennett Selby Investments LP holds 654 shares of AMGN stock, worth $183,165. This represents 0.09% of its overall portfolio holdings.

Number of Shares
654
Previous 654 -0.0%
Holding current value
$183,165
Previous $204,000 2.94%
% of portfolio
0.09%
Previous 0.09%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 10, 2024

BUY
$262.75 - $319.31 $171,838 - $208,828
654 New
654 $204,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Bennett Selby Investments LP Portfolio

Follow Bennett Selby Investments LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bennett Selby Investments LP, based on Form 13F filings with the SEC.

News

Stay updated on Bennett Selby Investments LP with notifications on news.